A health care worker in New York prepares a Moderna vaccine. Michael M. Santiago/Getty ImagesEuropean regulators on April 21 cleared a combination vaccine made by Moderna that targets COVID-19 and influenza.Moderna’s messenger ribonucleic acid (mRNA) vaccine, mCombriax, is the first authorized combination flu–COVID shot after receiving clearance from the European Commission for individuals aged 50 and older.
European Regulators Approve Modernas mRNA InfluenzaCOVID Vaccine
Date:
